Whether you are a pharmaceutical, biotech or CRO company, you need a data-driven approach to drug development in order make informed decisions. We understand that you need a detailed view of the ever-changing competitive landscape across your clinical development portfolio to succeed. Phesi delivers advanced analytics and a systematic, integrated data science approach to reduce the cost of development, accelerate the process of getting new therapies to market, maximize commercial return, and facilitate more effective dialogue with regulatory authorities.
Phesi analyzes historical and ongoing clinical trials in all disease areas to determine the best indication, target product and patient profiles, and preferred study outcomes to increase the chances of clinical and commercial success for drug candidates.